Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic variants associated with response to anti-CGRP monoclonal antibody therapy in a chronic migraine Han Chinese population.

The journal of headache and pain - 12 Sept 2024

An Yu-Chin, Hung Kuo-Sheng, Liang Chih-Sung, Tsai Chia-Kuang, Tsai Chia-Lin, Chen Sy-Jou, Lin Yu-Kai, Lin Guan-Yu, Yeh Po-Kuan, Yang Fu-Chi

Abstract excerpt

BACKGROUND: Anti-calcitonin gene-related peptide (CGRP) monoclonal antibodies have emerged as promising therapeutic options for the treatment of chronic migraine. However, treatment response varies considerably among individuals, suggesting a potential role for genetic factors. This study aimed to identify genetic variants affecting the efficacy of anti-CGRP monoclonal antibody therapy in chronic migraine among...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal
Share to Antibodies, Monoclonal, Humanized

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Calcitonin Gene-Related Peptide

Share to Chronic Disease

Share to East Asian People

Share to Migraine Disorders

Share to Quantitative Trait Loci

Share to Taiwan

Source

Open in PubMed Open full text

Identifiers

PMID: 39266962
DOI: 10.1186/s10194-024-01850-y
PMCID: PMC11391721

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic variants associated with response to anti-CGRP monoclonal antibody therapy in a chronic migraine Han Chinese population.PMID 39266962Read ↗

Predictors of galcanezumab response in a real-world study of Korean patients with migraineSemantic proximity Read ↗

Genome-wide association analysis of treatment response to onabotulinumtoxinA in Han Chinese patients with chronic migraine: a pilot study.Semantic proximity Read ↗

Efficacy and safety of calcitonin-gene-related peptide binding monoclonal antibodies for the preventive treatment of episodic migraine – An updated systematic review and meta-analysisSemantic proximity Read ↗

Safety efficacy and tolerability of the calcitonin gene-related peptide monoclonal antibodies for migraine prevention in a real world settingSemantic proximity Read ↗

Genome-wide association study identifies novel susceptibility loci for migraine in Han Chinese resided in Taiwan.Semantic proximity Read ↗

Cgrp Monoclonal Antibodies: Key Lessons from Real World EvidenceSemantic proximity Read ↗

Monoclonal Antibodies Against Calcitonin Gene-related Peptide for Migraine Prophylaxis: A Systematic Review of Real-world DataSemantic proximity Read ↗

Multi-omics Mendelian randomization integrating GWAS, eQTL and pQTL data revealed GSTM4 as a potential drug target for migraine.Semantic proximity Read ↗

Unveiling the Efficacy and Safety of Erenumab, a Monoclonal Antibody Targeting Calcitonin Gene-related Peptide (CGRP) Receptor, in Patients with Chronic and Episodic Migraine: A GRADE-assessed Systematic Review and Meta-analysis of Randomized Clinical Trials with Subgroup AnalysisSemantic proximity Read ↗

Efficacy and Safety of CGRP Monoclonal Antibodies for the Prevention of Migraine Compared with Placebo: A Systematic Review and Meta-AnalysisSemantic proximity Read ↗

Biomarkers associated with migraine and their potential role in migraine management.Semantic proximity Read ↗

Effect of Calcitonin Gene-Related Peptide Receptor Antagonists on Migraine Treatment: A Meta-AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.